6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(4-methoxypyrimidin-2-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide

ID: ALA4776752

PubChem CID: 157028757

Max Phase: Preclinical

Molecular Formula: C22H23N7O4

Molecular Weight: 449.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(OC)n2)c1OC

Standard InChI:  InChI=1S/C22H23N7O4/c1-23-22(31)18-15(11-16(28-29-18)26-21(30)12-7-8-12)25-14-6-4-5-13(19(14)33-3)20-24-10-9-17(27-20)32-2/h4-6,9-12H,7-8H2,1-3H3,(H,23,31)(H2,25,26,28,30)/i1D3

Standard InChI Key:  XRWVUYRJQUAYSL-FIBGUPNXSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   36.3966  -14.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3955  -15.1327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.1035  -15.5417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.8132  -15.1323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8103  -14.3096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1017  -13.9043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6888  -13.9048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6886  -13.0876    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9812  -14.3135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.0993  -13.0871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.8058  -12.6764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5126  -13.0853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2186  -12.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2166  -11.8572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5027  -11.4509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7996  -11.8633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0890  -11.4598    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.0831  -10.6426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5215  -15.5397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.2286  -15.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9369  -15.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2273  -14.3128    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.3481  -16.2414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7556  -15.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2734  -13.9051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5658  -14.3139    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   34.2732  -13.0879    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   33.5626  -13.4960    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   38.4977  -10.6383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2044  -10.2257    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.1994   -9.4093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4885   -9.0045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7812   -9.4221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7896  -10.2371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.9046   -8.9964    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.6148   -9.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  1  0
  4 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 23 21  1  0
 24 23  1  0
 21 24  1  0
  9 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 15 29  1  0
 31 35  1  0
 35 36  1  0
M  ISO  3  26   2  27   2  28   2
M  END

Associated Targets(Human)

TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.47Molecular Weight (Monoisotopic): 449.1812AlogP: 2.40#Rotatable Bonds: 8
Polar Surface Area: 140.25Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.09CX Basic pKa: 3.73CX LogP: 2.93CX LogD: 2.93
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.36

References

1. Liu C,Lin J,Langevine C,Smith D,Li J,Tokarski JS,Khan J,Ruzanov M,Strnad J,Zupa-Fernandez A,Cheng L,Gillooly KM,Shuster D,Zhang Y,Thankappan A,McIntyre KW,Chaudhry C,Elzinga PA,Chiney M,Chimalakonda A,Lombardo LJ,Macor JE,Carter PH,Burke JR,Weinstein DS.  (2021)  Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.,  64  (1.0): [PMID:33370104] [10.1021/acs.jmedchem.0c01698]

Source